Ionis Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Ionis Pharmaceuticals patents 237 in total
| Status | Patent |
|---|---|
Grant | Utility: Compounds and methods for modulating angiotensinogen expression Filling date: 7 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Compounds and methods for reducing ATXN3 expression Filling date: 7 Sep 2025 Issue date: 6 Sep 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION Filling date: 7 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: MODULATORS OF HSD17B13 EXPRESSION Filling date: 7 Sep 2025 Issue date: 1 Sep 2022 |
Grant | Utility: Modulation of Huntington expression Filling date: 7 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Modified CRISPR RNA and modified single CRISPR RNA and uses thereof Filling date: 7 Sep 2025 Issue date: 16 Aug 2022 |
Application | Utility: SYNTHESIS OF OLIGOMERIC COMPOUNDS COMPRISING PHOSPHOROTHIOATE DIESTER AND PHOSPHODIESTER LINKAGES Filling date: 7 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: MODULATORS OF MALAT1 EXPRESSION Filling date: 7 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: MODULATORS OF IRF4 EXPRESSION Filling date: 7 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION Filling date: 7 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: MODULATORS OF COMPLEMENT FACTOR B Filling date: 7 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING FUS EXPRESSION Filling date: 7 Sep 2025 Issue date: 4 Aug 2022 |
Grant | Utility: Method of conjugating oligomeric compounds Filling date: 7 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: Compositions and Methods for Modulating MECP2 Expression Filling date: 7 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS Filling date: 7 Sep 2025 Issue date: 7 Jul 2022 |
Grant | Utility: Modulation of factor 11 expression Filling date: 7 Sep 2025 Issue date: 5 Jul 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION Filling date: 7 Sep 2025 Issue date: 23 Jun 2022 |
Grant | Utility: Modulators of EZH2 expression Filling date: 7 Sep 2025 Issue date: 21 Jun 2022 |
Application | Utility: LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS Filling date: 7 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: MODULATION OF PREKALLIKREIN (PKK) EXPRESSION Filling date: 7 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: COMPOSITIONS COMPRISING ALTERNATING 2'-MODIFIED NUCLEOSIDES FOR USE IN GENE MODULATION Filling date: 7 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: METHODS FOR REDUCING ATAXIN-2 EXPRESSION Filling date: 7 Sep 2025 Issue date: 26 May 2022 |
Grant | Utility: Compositions for modulating C9ORF72 expression Filling date: 7 Sep 2025 Issue date: 24 May 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION Filling date: 7 Sep 2025 Issue date: 19 May 2022 |
Grant | Utility: Compounds and methods for reducing LRRK2 expression Filling date: 7 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Modified compounds and uses thereof Filling date: 7 Sep 2025 Issue date: 17 May 2022 |
Application | Utility: METHODS OF TREATING BREAST CANCER Filling date: 7 Sep 2025 Issue date: 12 May 2022 |
Grant | Utility: Modulating apolipoprotein (a) expression Filling date: 7 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Compositions and methods for modulating growth hormone receptor expression Filling date: 7 Sep 2025 Issue date: 26 Apr 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING PMP22 EXPRESSION Filling date: 7 Sep 2025 Issue date: 14 Apr 2022 |
Grant | Utility: Conjugated antisense compounds and their use Filling date: 7 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Compositions and methods for modulating Ataxin 3 expression Filling date: 7 Sep 2025 Issue date: 5 Apr 2022 |
Grant | Utility: Modulators of MALAT1 expression Filling date: 7 Sep 2025 Issue date: 22 Mar 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS Filling date: 7 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: Compounds and Methods for Reducing ATXN2 Expression Filling date: 7 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING SMN2 Filling date: 7 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: MODULATORS OF IRF5 EXPRESSION Filling date: 7 Sep 2025 Issue date: 17 Feb 2022 |
Grant | Utility: Selective antisense compounds and uses thereof Filling date: 7 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Antisense compounds and uses thereof Filling date: 7 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Compounds and methods for reducing SNCA expression Filling date: 7 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Modulation of angiopoietin-like 3 expression Filling date: 7 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Modulators of IRF5 expression Filling date: 7 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION Filling date: 7 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: CHIRALLY ENRICHED OLIGOMERIC COMPOUNDS Filling date: 7 Sep 2025 Issue date: 9 Dec 2021 |
Grant | Utility: Compositions for modulating expression of C9ORF72 antisense transcript Filling date: 7 Sep 2025 Issue date: 7 Dec 2021 |
Application | Utility: OLIGONUCLEOTIDE MEDIATED NO-GO DECAY Filling date: 7 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING FXI EXPRESSION Filling date: 7 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: ALLELE SPECIFIC MODULATORS OF P23H RHODOPSIN Filling date: 7 Sep 2025 Issue date: 11 Nov 2021 |
Showing 1 to 50 of 237 patents.